Search details
1.
A comparative cost analysis of two screening strategies for colorectal cancer in Lynch Syndrome in a South African tertiary hospital.
Cancer Causes Control
; 34(2): 161-169, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36355273
2.
Rapid Point-of-Care Testing for Genital Tract Inflammatory Cytokine Biomarkers to Diagnose Asymptomatic Sexually Transmitted Infections and Bacterial Vaginosis in Women: Cost Estimation and Budget Impact Analysis.
Sex Transm Dis
; 49(3): 237-243, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34596633
3.
Provider- and patient-level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care.
Trop Med Int Health
; 25(12): 1553-1567, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32959434
4.
Cost of managing severe cutaneous adverse drug reactions to first-line tuberculosis therapy in South Africa.
Trop Med Int Health
; 24(8): 994-1002, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31173430
5.
Developing the Global Health Cost Consortium Unit Cost Study Repository for HIV and TB: methodology and lessons learned.
Afr J AIDS Res
; 18(4): 263-276, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31779571
6.
Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis.
J Antimicrob Chemother
; 72(7): 1871-1879, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-28419314
7.
Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
BMC Infect Dis
; 16(1): 593, 2016 Oct 21.
Article
in English
| MEDLINE | ID: mdl-27769174
8.
Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa.
Health Qual Life Outcomes
; 14: 42, 2016 Mar 11.
Article
in English
| MEDLINE | ID: mdl-26969306
9.
Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale.
Health Econ
; 25 Suppl 1: 53-66, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26763594
10.
Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
Trop Med Int Health
; 20(10): 1337-45, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-25975868
11.
Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa.
Cost Eff Resour Alloc
; 12: 20, 2014.
Article
in English
| MEDLINE | ID: mdl-25242892
12.
Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT).
BMJ Open
; 14(5): e084918, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38692732
13.
Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
Thorax
; 68(3): 247-55, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22717944
14.
Cost-effectiveness analysis of different screening and diagnostic strategies for sexually transmitted infections and bacterial vaginosis in women attending primary health care facilities in Cape Town.
Front Public Health
; 11: 1048091, 2023.
Article
in English
| MEDLINE | ID: mdl-36935688
15.
National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010-19: a data envelopment and stochastic frontier analysis.
Lancet Glob Health
; 10(5): e649-e660, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35427522
16.
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.
BMC Med
; 9: 54, 2011 May 12.
Article
in English
| MEDLINE | ID: mdl-21569406
17.
Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
PLoS One
; 16(5): e0251547, 2021.
Article
in English
| MEDLINE | ID: mdl-33989317
18.
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.
Pharmacoeconomics
; 38(8): 819-837, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32363543
19.
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.
Pharmacoeconomics
; 38(8): 899-900, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32462638
20.
A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.
PLoS One
; 14(4): e0214492, 2019.
Article
in English
| MEDLINE | ID: mdl-30943223